|
1
|
Schild SE, Scheithauer BW, Schomberg PJ,
Hook CC, Kelly PJ, Frick L, Robinow JS and Buskirk SJ: Pineal
parenchymal tumors. Clinical, pathologic, and therapeutic aspects.
Cancer. 72:870–880. 1993. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Jouvet A, Saint-Pierre G, Fauchon F,
Privat K, Bouffet E, Ruchoux MM, Chauveinc L and Fèvre-Montange M:
Pineal parenchymal tumors: a correlation of histological features
with prognosis in 66 cases. Brain Pathol. 10:49–60. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Louis DN, Ohgaki H, Wiestler OD, Cavenee
WK, Burger PC, Jouvet A, Scheithauer BW and Kleihues P: The 2007
WHO classification of tumours of the central nervous system. Acta
Neuropathol. 114:97–109. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Clark AJ, Ivan ME, Sughrue ME, Yang I,
Aranda D, Han SJ, Kane AJ and Parsa AT: Tumor control after surgery
and radiotherapy for pineocytoma. J Neurosurg. 113:319–324. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Clark AJ, Sughrue ME, Ivan ME, Aranda D,
Rutkowski MJ, Kane AJ, Chang S and Parsa AT: Factors influencing
overall survival rates for patients with pineocytoma. J Neurooncol.
100:255–260. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Fangusaro J, Finlay J, Sposto R, Ji L,
Saly M, Zacharoulis S, Asgharzadeh S, Abromowitch M, Olshefski R,
Halpern S, Dubowy R, Comito M, Diez B, Kellie S, Hukin J, Rosenblum
M, Dunkel I, Miller DC, Allen J and Gardner S: Intensive
chemotherapy followed by consolidative myeloablative chemotherapy
with autologous hematopoietic cell rescue (AuHCR) in young children
with newly diagnosed supratentorial primitive neuroectodermal
tumors (sPNETs): report of the Head Start I and II experience.
Pediatr Blood Cancer. 50:312–318. 2008.
|
|
7
|
Jouvet A, Fèvre-Montange M, Besançon R,
Derrington E, Saint-Pierre G, Belin MF, Pialat J and Lapras C:
Structural and ultrastructural characteristics of human pineal
gland, and pineal parenchymal tumors. Acta Neuropathol. 88:334–348.
1994. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Fauchon F, Jouvet A, Paquis P,
Saint-Pierre G, Mottolese C, Ben Hassel M, Chauveinc L, Sichez JP,
Philippon J, Schlienger M and Bouffet E: Parenchymal pineal tumors:
a clinicopathological study of 76 cases. Int J Radiat Oncol Biol
Phys. 46:959–968. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Maarouf M, El Majdoub F, Bührle C, Voges
J, Lehrke R, Kocher M, Hunsche S, Treuer H and Sturm V: Pineal
parenchymal tumors. Management with interstitial iodine-125
radiosurgery. Strahlenther Onkol. 186:127–134. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Stoiber EM, Schaible B, Herfarth K,
Schulz-Ertner D, Huber PE, Debus J and Oertel S: Long term outcome
of adolescent and adult patients with pineal parenchymal tumors
treated with fractionated radiotherapy between 1982 and 2003 - a
single institution’s experience. Radiat Oncol. 5:1222010.PubMed/NCBI
|
|
11
|
Lutterbach J, Fauchon F, Schild SE, Chang
SM, Pagenstecher A, Volk B, Ostertag C, Momm F and Jouvet A:
Malignant pineal parenchymal tumors in adult patients: patterns of
care and prognostic factors. Neurosurgery. 51:44–55. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Schild SE, Scheithauer BW, Haddock MG,
Wong WW, Lyons MK, Marks LB, Norman MG and Burger PC:
Histologically confirmed pineal tumors and other germ cell tumors
of the brain. Cancer. 78:2564–2571. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Aoki T, Takahashi JA, Ueba T, Oya N,
Hiraoka M, Matsui K, Fukui T, Nakashima Y, Ishikawa M and Hashimoto
N: Phase II study of nimustine, carboplatin, vincristine, and
interferon-β with radiotherapy for glioblastoma multiforme:
experience of the Kyoto Neuro-Oncology Group. J Neurosurg.
105:385–391. 2006.PubMed/NCBI
|
|
14
|
Packer RJ, Lange B, Ater J, Nicholson HS,
Allen J, Walker R, Prados M, Jakacki R, Reaman G and Needles MN:
Carboplatin and vincristine for recurrent and newly diagnosed
low-grade gliomas of childhood. J Clin Oncol. 11:850–856. 1993.
|
|
15
|
Packer RJ, Sutton LN, Elterman R, et al:
Outcome for children with medulloblastoma treated with radiation
and cisplatin, CCNU, and vincristine chemotherapy. J Neurosurg.
81:690–698. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Wakabayashi T, Hatano N, Kajita Y, Yoshida
T, Mizuno M, Taniguchi K, Ohno T, Nagasaka T and Yoshida J: Initial
and maintenance combination treatment with interferon-beta, MCNU
(ranimustine), and radiotherapy for patients with previously
untreated malignant glioma. J Neurooncol. 49:57–62. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Natsume A, Ishii D, Wakabayashi T, Tsuno
T, Hatano H, Mizuno M and Yoshida J: IFN-beta down-regulates the
expression of DNA repair gene MGMT and sensitizes resistant glioma
cells to temozolomide. Cancer Res. 65:7573–7579. 2005.PubMed/NCBI
|
|
18
|
Kurisaka M, Arisawa M, Mori T, Sakamoto T,
Seike M, Mori K, Okada T, Wakiguchi H and Kurashige T: Combination
chemotherapy (cisplatin, vinblastin) and low-dose irradiation in
the treatment of pineal parenchymal cell tumors. Childs Nerv Syst.
14:564–569. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Hinkes BG, von Hoff K, Deinlein F,
Warmuth-Metz M, Soerensen N, Timmermann B, Mittler U, Urban C, Bode
U, Pietsch T, Schlegel PG, Kortmann RD, Kuehl J and Rutkowski S:
Childhood pineoblastoma: experiences from the prospective
multicenter trials HIT-SKK87, HIT-SKK92 and HIT91. J Neurooncol.
81:217–223. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Li G, Mitra S, Karamchandani J, Edwards MS
and Wong AJ: Pineal parenchymal tumor of intermediate
differentiation: clinicopathological report and analysis of
epidermal growth factor receptor variant III expression.
Neurosurgery. 66:963–968. 2010. View Article : Google Scholar
|
|
21
|
Crossen JR, Garwood D, Glatstein E and
Neuwelt EA: Neurobehavioral sequelae of cranial irradiation in
adults: a review of radiation-induced encephalopathy. J Clin Oncol.
12:627–642. 1994.PubMed/NCBI
|
|
22
|
Monje ML, Mizumatsu S, Fike JR and Palmer
TD: Irradiation induces neural precursor-cell dysfunction. Nat Med.
8:955–962. 2002. View
Article : Google Scholar : PubMed/NCBI
|
|
23
|
Mizumatsu S, Monje ML, Morhardt DR, Rola
R, Palmer TD and Fike JR: Extreme sensitivity of adult neurogenesis
to low doses of X-irradiation. Cancer Res. 63:4021–4027.
2003.PubMed/NCBI
|
|
24
|
Redmond KJ, Mahone EM, Terezakis S, Ishaq
O, Ford E, McNutt T, Kleinberg L, Cohen KJ, Wharam M and Horska A:
Association between radiation dose to neuronal progenitor cell
niches and temporal lobes and performance on neuropsychological
testing in children: a prospective study. Neuro Oncol. 15:360–369.
2013. View Article : Google Scholar
|
|
25
|
Gong X, Schwartz PH, Linskey ME and Bota
DA: Neural stem/progenitors and glioma stem-like cells have
differential sensitivity to chemotherapy. Neurology. 76:1126–1134.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Brown WR, Blair RM, Moody DM, Thore CR,
Ahmed S, Robbins ME and Wheeler KT: Capillary loss precedes the
cognitive impairment induced by fractionated whole-brain
irradiation: a potential rat model of vascular dementia. J Neurol
Sci. 257:67–71. 2007. View Article : Google Scholar : PubMed/NCBI
|
